 GENEVA, Switzerland and BOSTON, MA May 6 , 2021 ObsEva SA NASDAQ: OBSV SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced the appointment of Clive Bertram as Chief Commercial Officer and member of ObsEvas Executive Committee, effective May 10, 2021. Wim Souverijns has served as Chief Commercial Officer of ObsEva since November 2018 and will leave the Company on June 30, 2021 to pursue a new opportunity. He will work to ensure a smooth transition with Clive Bertram. 